These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21872979)

  • 1. β-Blockers for prevention of sudden cardiac death in patients on hemodialysis: a propensity score analysis of the HEMO Study.
    Tangri N; Shastri S; Tighiouart H; Beck GJ; Cheung AK; Eknoyan G; Sarnak MJ
    Am J Kidney Dis; 2011 Dec; 58(6):939-45. PubMed ID: 21872979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-Blocker Use and Risk of Mortality in Heart Failure Patients Initiating Maintenance Dialysis.
    Zhou H; Sim JJ; Shi J; Shaw SF; Lee MS; Neyer JR; Kovesdy CP; Kalantar-Zadeh K; Jacobsen SJ
    Am J Kidney Dis; 2021 May; 77(5):704-712. PubMed ID: 33010357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Beta-Blockers on Maintenance Dialysis Patients and Ischemic Cerebral and Cardiovascular Deaths: An Examination Using Propensity Score.
    Omae K; Ogawa T; Yoshikawa M; Sakura H; Nitta K
    Contrib Nephrol; 2018; 195():120-130. PubMed ID: 29734157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wasting and sudden cardiac death in hemodialysis patients: a post hoc analysis of 4D (Die Deutsche Diabetes Dialyse Studie).
    Drechsler C; Grootendorst DC; Pilz S; Tomaschitz A; Krane V; Dekker F; März W; Ritz E; Wanner C
    Am J Kidney Dis; 2011 Oct; 58(4):599-607. PubMed ID: 21820222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10-Year Cohort.
    Tang CH; Wang CC; Chen TH; Hong CY; Sue YM
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26738790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of recurrent ventricular arrhythmia or death in 300 consecutive patients with ischemic heart disease who experienced aborted sudden death: data from the Leiden out-of-hospital cardiac arrest study.
    Kiès P; Boersma E; Bax JJ; van der Burg AE; Bootsma M; van Erven L; van der Wall EE; Schalij MJ
    J Cardiovasc Electrophysiol; 2005 Oct; 16(10):1049-56. PubMed ID: 16191114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-blocker prevents sudden cardiac death in patients with hemodialysis.
    Matsue Y; Suzuki M; Nagahori W; Ohno M; Matsumura A; Hashimoto Y
    Int J Cardiol; 2013 May; 165(3):519-22. PubMed ID: 21996409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-Blockers for the prevention of sudden cardiac death in heart failure patients: a meta-analysis of randomized controlled trials.
    Al-Gobari M; El Khatib C; Pillon F; Gueyffier F
    BMC Cardiovasc Disord; 2013 Jul; 13():52. PubMed ID: 23848972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrovascular disease in maintenance hemodialysis patients: results of the HEMO Study.
    Delmez JA; Yan G; Bailey J; Beck GJ; Beddhu S; Cheung AK; Kaysen GA; Levey AS; Sarnak MJ; Schwab SJ;
    Am J Kidney Dis; 2006 Jan; 47(1):131-8. PubMed ID: 16377394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States.
    Charytan DM; Patrick AR; Liu J; Setoguchi S; Herzog CA; Brookhart MA; Winkelmayer WC
    Am J Kidney Dis; 2011 Sep; 58(3):409-17. PubMed ID: 21664735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary prevention implantable cardioverter defibrillators in end-stage kidney disease patients on dialysis: a matched cohort study.
    Pun PH; Hellkamp AS; Sanders GD; Middleton JP; Hammill SC; Al-Khalidi HR; Curtis LH; Fonarow GC; Al-Khatib SM
    Nephrol Dial Transplant; 2015 May; 30(5):829-35. PubMed ID: 25404241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The intuitive case for β-blockers in patients with ESRD.
    McQuillan RF; Chan CT
    Semin Dial; 2012; 25(1):15-21. PubMed ID: 22273523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-blockers for coronary heart disease in chronic kidney disease.
    Chonchol M; Benderly M; Goldbourt U
    Nephrol Dial Transplant; 2008 Jul; 23(7):2274-9. PubMed ID: 18187497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched-cohort analysis from the High-Risk Myocardial Infarction Database Initiative.
    Coiro S; Girerd N; Rossignol P; Ferreira JP; Maggioni A; Pitt B; Tritto I; Ambrosio G; Dickstein K; Zannad F
    Eur J Heart Fail; 2017 Feb; 19(2):271-279. PubMed ID: 27774703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Oxalate Concentrations Correlate with Increased Risk for Sudden Cardiac Death in Dialysis Patients.
    Pfau A; Ermer T; Coca SG; Tio MC; Genser B; Reichel M; Finkelstein FO; März W; Wanner C; Waikar SS; Eckardt KU; Aronson PS; Drechsler C; Knauf F
    J Am Soc Nephrol; 2021 Sep; 32(9):2375-2385. PubMed ID: 34281958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy-associated plasma protein A associates with cardiovascular events in diabetic hemodialysis patients.
    Kalousová M; Zima T; Krane V; März W; Wanner C; Tesař V; Drechsler C;
    Atherosclerosis; 2014 Oct; 236(2):263-9. PubMed ID: 25108075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable cardioverter-defibrillators in patients with CKD: a propensity-matched mortality analysis.
    Nakhoul GN; Schold JD; Arrigain S; Harb SC; Jolly S; Wilkoff BL; Nally JV; Navaneethan SD
    Clin J Am Soc Nephrol; 2015 Jul; 10(7):1119-27. PubMed ID: 26111859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for sudden cardiac death in patients with chronic renal insufficiency and left ventricular dysfunction.
    Chonchol M; Goldenberg I; Moss AJ; McNitt S; Cheung AK
    Am J Nephrol; 2007; 27(1):7-14. PubMed ID: 17204832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefit of Vasodilating β-Blockers in Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention: Nationwide Multicenter Cohort Study.
    Chung J; Han JK; Kim YJ; Kim CJ; Ahn Y; Chan Cho M; Chae SC; Chae IH; Chae JK; Seong IW; Yang HM; Park KW; Kang HJ; Koo BK; Jeong MH; Kim HS;
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased Mortality With Beta-Blockers in Patients With Heart Failure and Coexisting Atrial Fibrillation: An AF-CHF Substudy.
    Cadrin-Tourigny J; Shohoudi A; Roy D; Talajic M; Tadros R; Mondésert B; Dyrda K; Rivard L; Andrade JG; Macle L; Guerra PG; Thibault B; Dubuc M; Khairy P
    JACC Heart Fail; 2017 Feb; 5(2):99-106. PubMed ID: 28089316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.